Contact Us
Juvenile Idiopathic Arthritis Diagnostic Global Market Report 2025
Global Juvenile Idiopathic Arthritis Diagnostic Market Report 2025
Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Juvenile Idiopathic Arthritis Diagnostic Global Market Report 2025

By Type (Serological Tests, Imaging Tests, Genetic Tests), By Technology (Molecular Diagnostics, Immunoassays, Flow Cytometry), By Services (Diagnostic Services, Consultation Services, Laboratory Services), By Application (Hospital Laboratories, Diagnostic Centres, Research Institutes) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Juvenile Idiopathic Arthritis Diagnostic Market Overview

• Juvenile Idiopathic Arthritis Diagnostic market size has reached to $4.75 billion in 2024

• Expected to grow to $6.27 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: Rising Prevalence Of Autoimmune Disorders Driving Growth Of The Market Due To Increasing Cases Of Immune-Mediated Joint Inflammation

• Market Trend: Strategic Partnerships Driving Innovation In Autoimmune Diagnostics

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Juvenile Idiopathic Arthritis Diagnostic Market?

Juvenile idiopathic arthritis (JIA) diagnostic refers to the medical processes and tests used to identify JIA, a chronic autoimmune condition in children that causes persistent joint inflammation, pain, and stiffness, potentially leading to long-term joint damage and mobility issues. It is caused by an overactive immune system mistakenly attacking the body's own joint tissues due to genetic and environmental factors, triggering inflammation that, if left untreated, can result in growth complications, vision problems, and reduced quality of life.

The main types of juvenile idiopathic arthritis diagnostics are serological tests, imaging tests, and Genetic Tests. Serological tests involve blood analysis to identify specific markers that indicate inflammation or autoimmune activity associated with JIA. Key technologies utilized in JIA diagnostics include molecular diagnostics, immunoassays, and flow cytometry. The services offered encompass diagnostic services, consultation services, and laboratory services and are applied across various settings, including hospital laboratories, diagnostic centers, and research institutes.

Juvenile Idiopathic Arthritis Diagnostic Market Size and growth rate 2025 to 2029: Graph

What Is The Juvenile Idiopathic Arthritis Diagnostic Market Size 2025 And Growth Rate?

The juvenile idiopathic arthritis diagnostic market size has grown strongly in recent years. It will grow from $4.75 billion in 2024 to $5.03 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to growing prevalence of juvenile idiopathic arthritis, increased awareness of pediatric autoimmune conditions, early detection, increased healthcare investments, and rising focus on pediatric care.

What Is The Juvenile Idiopathic Arthritis Diagnostic Market Growth Forecast?

The juvenile idiopathic arthritis diagnostic market size is expected to see strong growth in the next few years. It will grow to $6.27 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing collaborations between research institutions, rising demand for early and accurate diagnostic solutions, increasing cases of autoimmune and inflammatory disorders, government and healthcare organizations initiatives, and rise of telemedicine and digital health platforms. Major trends in the forecast period include technological advancements, advancements in diagnostic technologies, personalized treatment strategies, advances in diagnostic technologies, innovations in diagnostic tools.

The forecast of 5.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of advanced cytokine testing kits and pediatric MRI contrast agents sourced from Belgium and Japan, thereby delaying accurate diagnosis and elevating pediatric rheumatology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Juvenile Idiopathic Arthritis Diagnostic Market Segmented?

1) By Type: Serological Tests, Imaging Tests, Genetic Tests

2) By Technology: Molecular Diagnostics, Immunoassays, Flow Cytometry

3) By Services: Diagnostic Services, Consultation Services, Laboratory Services

4) By Application: Hospital Laboratories, Diagnostic Centres, Research Institutes

Subsegments:

1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)

2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)

3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing

What Is Driving The Juvenile Idiopathic Arthritis Diagnostic Market? Rising Prevalence Of Autoimmune Disorders Driving Growth Of The Market Due To Increasing Cases Of Immune-Mediated Joint Inflammation

The increasing prevalence of autoimmune disorders is expected to propel the juvenile idiopathic arthritis diagnostic market going forward. Autoimmune disorders refer to conditions in which the immune system mistakenly attacks the body's healthy cells, causing inflammation, tissue damage, and chronic health complications. The rise in autoimmune diseases is attributed to a complex interplay of environmental triggers, genetic predispositions, and lifestyle changes. Autoimmune diseases cause juvenile idiopathic arthritis (JIA) by triggering the immune system to mistakenly attack the synovial tissue in joints, leading to inflammation and damage. For instance, in November 2024, according to the Versorgungsatlas.de, a Germany-based interactive online platform, in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Therefore, the increasing prevalence of autoimmune disorders is driving the growth of the juvenile idiopathic arthritis diagnostic industry.

Who Are The Major Players In The Global Juvenile Idiopathic Arthritis Diagnostic Market?

Major companies operating in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech , Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, Avecon Healthcare.

What Are The Key Trends Of The Global Juvenile Idiopathic Arthritis Diagnostic Market? Strategic Partnerships Driving Innovation In Autoimmune Diagnostics

Major companies operating in the juvenile idiopathic arthritis diagnostic market are focusing on strategic partnerships to expand their product offerings, enhance research capabilities, and strengthen their market presence globally. Strategic partnerships refer to collaborations between organizations aimed at advancing early detection and diagnosis. For instance, in November 2024, Augurex Life Sciences Corp., a Canada-based biotechnology company, partnered with Quest Diagnostics, a US-based diagnostic services company, to improve the diagnosis and management of rheumatoid arthritis (RA) using the 14-3-3? (eta) biomarker. As part of the collaboration, Quest Diagnostics will validate and offer a lab-developed test in the United States based on Augurex’s 14-3-3? biomarker. The test is intended to detect elevated levels of the 14-3-3? protein, which is linked to rheumatoid arthritis and associated with increased disease severity and risk of joint damage.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Juvenile Idiopathic Arthritis Diagnostic Market? Globus Medical Merges with NuVasive for Comprehensive Solutions

In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. to offer surgeons and patients a comprehensive range of musculoskeletal procedural solutions and advanced technologies, improving the overall continuum of care. The combined entity is expected to strengthen complementary global operations, broaden its market presence, and significantly expand its portfolio in arthritis and orthopedic treatment solutions. NuVasive, Inc. is a US-based medical device company that specializes in developing medical devices and procedures for orthopedic and idiopathic conditions.

What Is The Regional Outlook For The Global Juvenile Idiopathic Arthritis Diagnostic Market?

North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Juvenile Idiopathic Arthritis Diagnostic Market?

The juvenile idiopathic arthritis diagnostic market consists of revenues earned by entities by providing services such as clinical evaluations, blood tests, ophthalmologic screenings, bone density scans, and synovial fluid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The juvenile idiopathic arthritis diagnostic market also includes sales of bone density scanners, AI-based diagnostic software, imaging equipment, and biomarker-based diagnostic panels. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Juvenile Idiopathic Arthritis Diagnostic Industry?

The juvenile idiopathic arthritis diagnostic market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the juvenile idiopathic arthritis diagnostic industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Juvenile Idiopathic Arthritis Diagnostic Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $5.03 billion
Revenue Forecast In 2034 $6.27 billion
Growth Rate CAGR of 5.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The juvenile idiopathic arthritis diagnostic market covered in this report is segmented –
1) By Type: Serological Tests, Imaging Tests, Genetic Tests
2) By Technology: Molecular Diagnostics, Immunoassays, Flow Cytometry
3) By Services: Diagnostic Services, Consultation Services, Laboratory Services
4) By Application: Hospital Laboratories, Diagnostic Centres, Research Institutes Subsegments:
1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Request for Sample
Customization ScopeExplore Purchase Options
Pricing And Purchase Options

Table Of Contents

1. Executive Summary

2. Juvenile Idiopathic Arthritis Diagnostic Market Characteristics

3. Juvenile Idiopathic Arthritis Diagnostic Market Trends And Strategies

4. Juvenile Idiopathic Arthritis Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Juvenile Idiopathic Arthritis Diagnostic Growth Analysis And Strategic Analysis Framework

5.1. Global Juvenile Idiopathic Arthritis Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate Analysis

5.4. Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Juvenile Idiopathic Arthritis Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Juvenile Idiopathic Arthritis Diagnostic Total Addressable Market (TAM)

6. Juvenile Idiopathic Arthritis Diagnostic Market Segmentation

6.1. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Serological Tests

Imaging Tests

Genetic Tests

6.2. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Molecular Diagnostics

Immunoassays

Flow Cytometry

6.3. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Services

Consultation Services

Laboratory Services

6.4. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Laboratories

Diagnostic Centers

Research Institutes

6.5. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rheumatoid Factor (RF) Test

Antinuclear Antibody (ANA) Test

Erythrocyte Sedimentation Rate (ESR) Test

C-Reactive Protein (CRP) Test

Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test

Complete Blood Count (CBC)

6.6. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

X-Ray

Magnetic Resonance Imaging (MRI)

Ultrasound

Computed Tomography (CT) Scan

Bone Scintigraphy (Bone Scan)

6.7. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Genetic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

HLA-B27 Genetic Marker Test

Whole Exome Sequencing (WES)

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)-Based Testing

7. Juvenile Idiopathic Arthritis Diagnostic Market Regional And Country Analysis

7.1. Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market

8.1. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Juvenile Idiopathic Arthritis Diagnostic Market

9.1. China Juvenile Idiopathic Arthritis Diagnostic Market Overview

9.2. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Juvenile Idiopathic Arthritis Diagnostic Market

10.1. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Juvenile Idiopathic Arthritis Diagnostic Market

11.1. Japan Juvenile Idiopathic Arthritis Diagnostic Market Overview

11.2. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Juvenile Idiopathic Arthritis Diagnostic Market

12.1. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market

13.1. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Juvenile Idiopathic Arthritis Diagnostic Market

14.1. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Overview

14.2. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market

15.1. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview

15.2. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Juvenile Idiopathic Arthritis Diagnostic Market

16.1. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Juvenile Idiopathic Arthritis Diagnostic Market

17.1. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Juvenile Idiopathic Arthritis Diagnostic Market

18.1. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Juvenile Idiopathic Arthritis Diagnostic Market

19.1. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Juvenile Idiopathic Arthritis Diagnostic Market

20.1. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market

21.1. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview

21.2. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Juvenile Idiopathic Arthritis Diagnostic Market

22.1. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Juvenile Idiopathic Arthritis Diagnostic Market

23.1. North America Juvenile Idiopathic Arthritis Diagnostic Market Overview

23.2. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Juvenile Idiopathic Arthritis Diagnostic Market

24.1. USA Juvenile Idiopathic Arthritis Diagnostic Market Overview

24.2. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Juvenile Idiopathic Arthritis Diagnostic Market

25.1. Canada Juvenile Idiopathic Arthritis Diagnostic Market Overview

25.2. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Juvenile Idiopathic Arthritis Diagnostic Market

26.1. South America Juvenile Idiopathic Arthritis Diagnostic Market Overview

26.2. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Juvenile Idiopathic Arthritis Diagnostic Market

27.1. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Juvenile Idiopathic Arthritis Diagnostic Market

28.1. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Overview

28.2. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Juvenile Idiopathic Arthritis Diagnostic Market

29.1. Africa Juvenile Idiopathic Arthritis Diagnostic Market Overview

29.2. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Juvenile Idiopathic Arthritis Diagnostic Market Competitive Landscape And Company Profiles

30.1. Juvenile Idiopathic Arthritis Diagnostic Market Competitive Landscape

30.2. Juvenile Idiopathic Arthritis Diagnostic Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Agilent Technologies Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Juvenile Idiopathic Arthritis Diagnostic Market Other Major And Innovative Companies

31.1. Sysmex Corporation

31.2. Bio-Rad Laboratories

31.3. Beckman Coulter Life Sciences

31.4. DiaSorin

31.5. Miltenyi Biotec

31.6. Cytek Biosciences

31.7. BD Biosciences

31.8. Angstrom Biotech

31.9. Sony Biotechnology

31.10. Theradiag

31.11. J. Mitra

31.12. Chimera Biotech

31.13. Stratedigm

31.14. Apogee Flow Systems

31.15. Avecon Healthcare

32. Global Juvenile Idiopathic Arthritis Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Juvenile Idiopathic Arthritis Diagnostic Market

34. Recent Developments In The Juvenile Idiopathic Arthritis Diagnostic Market

35. Juvenile Idiopathic Arthritis Diagnostic Market High Potential Countries, Segments and Strategies

35.1 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Countries Offering Most New Opportunities

35.2 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Segments Offering Most New Opportunities

35.3 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Genetic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Thermo Fisher Scientific Inc. Financial Performance
  • Table 79: Abbott Laboratories Financial Performance
  • Table 80: Merck KGaA Financial Performance
  • Table 81: Agilent Technologies Financial Performance
  • Table 82: Sartorius AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Genetic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 79: Abbott Laboratories Financial Performance
  • Figure 80: Merck KGaA Financial Performance
  • Figure 81: Agilent Technologies Financial Performance
  • Figure 82: Sartorius AG Financial Performance

Frequently Asked Questions

Juvenile idiopathic arthritis (JIA) diagnostic refers to the medical processes and tests used to identify JIA, a chronic autoimmune condition in children that causes persistent joint inflammation, pain, and stiffness, potentially leading to long-term joint damage and mobility issues. It is caused by an overactive immune system mistakenly attacking the body's own joint tissues due to genetic and environmental factors, triggering inflammation that, if left untreated, can result in growth complications, vision problems, and reduced quality of life. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Autoimmune Disorders Driving Growth Of The Market Due To Increasing Cases Of Immune-Mediated Joint Inflammation. For further insights on this market, request a sample here

The juvenile idiopathic arthritis diagnostic market size has grown strongly in recent years. It will grow from $4.75 billion in 2024 to $5.03 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to growing prevalence of juvenile idiopathic arthritis, increased awareness of pediatric autoimmune conditions, early detection, increased healthcare investments, and rising focus on pediatric care. The juvenile idiopathic arthritis diagnostic market size is expected to see strong growth in the next few years. It will grow to " $6.27 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing collaborations between research institutions, rising demand for early and accurate diagnostic solutions, increasing cases of autoimmune and inflammatory disorders, government and healthcare organizations initiatives, and rise of telemedicine and digital health platforms. Major trends in the forecast period include technological advancements, advancements in diagnostic technologies, personalized treatment strategies, advances in diagnostic technologies, innovations in diagnostic tools. For further insights on this market, request a sample here

The juvenile idiopathic arthritis diagnosticmarket covered in this report is segmented –
1) By Type: Serological Tests; Imaging Tests; Genetic Tests
2) By Technology: Molecular Diagnostics; Immunoassays; Flow Cytometry
3) By Services: Diagnostic Services; Consultation Services; Laboratory Services
4) By Application: Hospital Laboratories; Diagnostic Centres; Research Institutes Subsegments:
1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing For further insights on this market,
request a sample here

North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the juvenile idiopathic arthritis diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech , Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, Avecon Healthcare. . For further insights on this market, request a sample here.

Major trends in this market include Strategic Partnerships Driving Innovation In Autoimmune Diagnostics. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon